Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
06/2003
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/11/2003EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317487A2 Caveolin peptides and their use as therapeutics
06/11/2003EP1317476A2 Reagents for cell selection and methods of use
06/11/2003EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
06/11/2003EP0848755B1 Vegf-related protein
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element
06/11/2003CN1422869A Diphtherin-gonadoliberin chimeric protein
06/11/2003CN1422868A Receptor targeting chimeric toxin with junctional sequence
06/11/2003CN1422863A Recombinant chimeric peptide antigen detecting HCMV antibody and production method thereof
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576456 Chimeric adenovirus fiber protein
06/10/2003CA2065323C Isolation and purification of lung surfactant protein
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046134A2 Expression of polypeptides in rod outer segment membranes
06/05/2003WO2003046013A1 Fusion protein having enhanced in vivo activity of erythropoietin
06/05/2003WO2003045997A2 Fusion proteins containing tlp peptides
06/05/2003WO2003045429A2 Anti-t cell immunotoxin fusion protein and its therapeutic use
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
06/05/2003US20030105006 For therapy of bacterial infections
06/05/2003US20030104578 Secreted in yeast; storage stability; microbiocides
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104504 Chemical modification
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104490 High throughput assay for use in treatment and monitoring of diabetes
06/05/2003US20030104479 Novel fusion proteins and assays for molecular binding
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104355 Adapter-directed display systems
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030103987 Contacting cells of patient with protein having toxic activity of Clostridium sordellii toxin LT under conditions favoring inactivating of Ras by glucosylation of Ras'threonine 35 in cells
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103967 Administering an immunomodulator comprising at least one Fc receptor ligand for treating immune disorders such as allergies, transplanted tissue rejection and autoimmune disorders lupus, rheumatoid arthritis and multiple sclerosis
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003CA2468718A1 Fusion proteins containing tlp peptides
06/05/2003CA2467202A1 Expression of polypeptides in rod outer segment membranes
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315810A2 Family member of inhibitor of apoptosis proteins
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP0859838B1 Novel procollagens
06/04/2003EP0670730B1 Fusion protein comprising two tumor necrosis factor receptors
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1421529A Recombinant Flt3 ligand gene and its fusion gene and product
06/04/2003CN1421461A Fusion protein with reinforced erythrocytin activity in vivo
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110557C LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idio type antibody
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573236 Myelin oligodendrocyte glycoprotein (MOG) polypeptide-specific antibody to bind a natural MOG polypeptide and competitively inhibit the binding of an autoantibody, does not comprise functional Fc portion; multiple sclerosis
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573059 DNA construct for the preparation of a fusion protein; green fluorescent protein
06/03/2003US6572860 ICP27, glycoprotein B, ribonucleotide reductase, ICP4, ICP34.5, glycoprotein E or glycoprotein F and an immunomodulatory peptide which is a portion of an immunoprotein which promotes binding to a class of T cells and
05/2003
05/30/2003WO2003044051A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003014721A3 Chimeric protein and its use in electron transfer methods
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/29/2003US20030100743 Nucleic acids and proteins with thioredoxin reductase activity
05/29/2003US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases
05/29/2003US20030100047 Testis-specific receptor
05/29/2003US20030100046 Testis-specific receptor
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099608 Human cytokine receptor
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine
05/28/2003CN1420789A Compound for targeting
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 295